Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

NCT02334254 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

420

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: rivaroxaban and ticagrel therapy
DRUG: triple antithrombotic regimen with warfarin, asipirin and clopidogrel

Sponsor

Beijing Anzhen Hospital